Literature DB >> 10385260

Bradykinin down-regulates LPS-induced eosinophil accumulation in the pleural cavity of mice through type 2-kinin receptor activation: a role for prostaglandins.

A R Silva1, A P Larangeira, P Pacheco, J B Calixto, M G Henriques, P T Bozza, H C Castro-Faria-Neto.   

Abstract

1. The role of both exogenously administered and endogenously generated bradykinin (BK) on LPS-induced eosinophil accumulation in the mice pleural cavity was investigated by means of treatment with BK selective receptor agonists/antagonists and captopril. 2. Intrathoracic (i.t.) injection of LPS (250 ng cavity(-1)) induced eosinophil influx at 24 h as previously described (Bozza et al., 1993). Pretreatment with the B1 receptor antagonist des-Arg9-[leu-8]BK (0.025 and 0.25 nmol cavity(-1)) showed no effect on this phenomenon, whereas pretreatment with the B2 receptor antagonists, NPC 17731 (0.025 and 0.25 nmol cavity(-1)) or HOE 140 (2.5 nmol cavity(-1)), increased LPS-induced eosinophil influx. Accordingly, pretreatment with captopril at 10 mg kg(-1) i.p., inhibited eosinophil infiltration induced by LPS in the pleural cavity, suggesting that endogenous BK is down-regulating LPS-induced eosinophil accumulation. 3. BK administered at 15 and 25 nmol cavity(-1), i.t. or i.p. also inhibited LPS-induced eosinophil accumulation. BK alone had no effect on the basal number of leucocytes in the pleural or peritoneal cavity in doses up to 25 nmol cavity(-1). Nevertheless, when injected at doses of 50 and 100 nmol cavity(-1) BK induced leucocyte influx characterized by neutrophil and eosinophil accumulation at 24 h. 4. Similarly to what was observed with BK, a specific B2 receptor agonist, Tyr8BK, administered at 0.25 nmol cavity(-1) i.p., significantly inhibited the eosinophil influx induced by LPS. 5. The mechanism by which B2 receptor agonists inhibit LPS-induced eosinophil accumulation was investigated by pretreating the animals with indomethacin or a selective cyclooxygenase-2 inhibitor, NS-398. Pretreatment with either indomethacin or NS-398 had no effect on eosinophil influx induced by LPS alone, but those drugs were able to restore the LPS-induced eosinophil influx in Tyr8BK (0.25 nmol cavity(-1)) injected mice. 6. In conclusion, endogenously generated bradykinin seems to modulate, through activation of B2 receptors, eosinphil accumulation induced by LPS via a mechanism dependent on prostanoid synthesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385260      PMCID: PMC1566038          DOI: 10.1038/sj.bjp.0702567

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

Review 1.  Kinin B1 receptors: a review.

Authors:  F Marceau
Journal:  Immunopharmacology       Date:  1995-06

2.  The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).

Authors:  M M Campos; M G Henriques; J B Calixto
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

3.  Relationship between nitric oxide and prostaglandins in carrageenin pleurisy.

Authors:  L Sautebin; A Ialenti; A Ianaro; M Di Rosa
Journal:  Biochem Pharmacol       Date:  1998-04-01       Impact factor: 5.858

4.  Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis.

Authors:  H H Ferreira; M V Medeiros; C S Lima; C A Flores; P Sannomiya; E Autunes; G De Nucci
Journal:  Eur J Pharmacol       Date:  1996-08-29       Impact factor: 4.432

5.  Involvement of prostaglandins in the down-regulation of allergic plasma leakage observed in rats undergoing pleural eosinophilia.

Authors:  C Bandeira-Melo; Y Singh; R S Cordeiro; P M e Silva; M A Martins
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation.

Authors:  M M Teixeira; A G Rossi; M A Giembycz; P G Hellewell
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.

Authors:  M M Campos; G E Souza; J B Calixto
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 8.  Bradykinin B2 receptor antagonists: development and applications.

Authors:  J M Stewart
Journal:  Can J Physiol Pharmacol       Date:  1995-07       Impact factor: 2.273

9.  The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis.

Authors:  S C Cruwys; N E Garrett; M N Perkins; D R Blake; B L Kidd
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Involvement of bradykinin B1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 beta in vivo in the mouse.

Authors:  A Ahluwalia; M Perretti
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

View more
  1 in total

Review 1.  Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction.

Authors:  Eloísa Salvo-Romero; Bruno K Rodiño-Janeiro; Mercé Albert-Bayo; Beatriz Lobo; Javier Santos; Ricard Farré; Cristina Martinez; María Vicario
Journal:  Cells       Date:  2022-05-14       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.